{"name":"Stempeutics Research Pvt Ltd","slug":"stempeutics-research-pvt-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ex- vivo cultured adult allogeneic MSCs","genericName":"Ex- vivo cultured adult allogeneic MSCs","slug":"ex-vivo-cultured-adult-allogeneic-mscs","indication":"Osteoarthritis","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Allogeneic Mesenchymal Stem Cells","genericName":"Allogeneic Mesenchymal Stem Cells","slug":"allogeneic-mesenchymal-stem-cells","indication":"Treatment of graft-versus-host disease","status":"phase_2"}]}],"pipeline":[{"name":"Ex- vivo cultured adult allogeneic MSCs","genericName":"Ex- vivo cultured adult allogeneic MSCs","slug":"ex-vivo-cultured-adult-allogeneic-mscs","phase":"phase_2","mechanism":"Ex- vivo cultured adult allogeneic MSCs are thought to exert their therapeutic effects through paracrine mechanisms, releasing various growth factors and cytokines that promote tissue repair and regeneration.","indications":["Osteoarthritis","Bone nonunion"],"catalyst":""},{"name":"Allogeneic Mesenchymal Stem Cells","genericName":"Allogeneic Mesenchymal Stem Cells","slug":"allogeneic-mesenchymal-stem-cells","phase":"phase_2","mechanism":"Allogeneic Mesenchymal Stem Cells are thought to exert immunomodulatory effects through the release of anti-inflammatory cytokines and growth factors.","indications":["Treatment of graft-versus-host disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-03","type":"pipeline","source":"Business Standard","summary":"Cipla, Stempeutics launch stem cell therapy for knee osteoarthritis - Business Standard","headline":"Cipla, Stempeutics launch stem cell therapy for knee osteoarthritis","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-28","type":"deal","source":"ET Pharma","summary":"MEDINET Japan, Stempeutics India ink deal for Stempeucel Cell Therapy for CLTI - ET Pharma","headline":"MEDINET Japan, Stempeutics India ink deal for Stempeucel Cell Therapy for CLTI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPSU56SU1yOUpnX2NUTm9FajNVRVJ2TldWLUE4SDgwdnNsSjhsY09keVBPaWZ2T1JUOWZLTEEzZ3lrNVJwMWlOTXhUUVV1LWQ1ZVVhSVlYSmRZbDdRalhQekhYbmJBNzZMM3oxR2xSVXdPRHBoV2NpTGJQLS1HVTBrdVZrbVh0SmpVUE8xMXRLZXhZdFFobTcyMTh0ajFSWXlaRzRRTnhpa2JsV09PSXBqZm01UlJrMGxyTFg4eXdSdGZxQU85a1B0TDBESHAzMUpCVkNZZ0Z6Vmk3NVlGVWtEcFdoY0tzaVRRSW1CN2M3OTFqWTNWVVE?oc=5","date":"2025-10-27","type":"pipeline","source":"ehealth.eletsonline.com","summary":"MEDINET Japan inks licensing pact with Stempeutics India for Stempeucel® therapy to treat Chronic Limb Threatening Ischemia - ehealth.eletsonline.com","headline":"MEDINET Japan inks licensing pact with Stempeutics India for Stempeucel® therapy to treat Chronic Limb Threatening Ische","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQX3FwcFhwT1lkVjNiV2VIX1lUM1hTcU5sWGdDS2hsQVhUcXc0QTU2V2YzeG5xTGZkN01QdmF1UHE2d1JMWUdjSGY5Z2Z6RHRfTy1uOVJkVmdKdU1CeXZQUmhtOEVHbjdvUkZoeXE4azh2UGY5Sm1oRi1nSWNwWHoyNGJ4UXdvQk1PNF9sX0lLaGNJOGZHTTZjVVJibFhtTlZxVk1YLXFEZ0VhSHBuLUww?oc=5","date":"2025-02-26","type":"pipeline","source":"BioSpace","summary":"Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203 - BioSpace","headline":"Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-05-11","type":"trial","source":"Express Pharma","summary":"Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer - Express Pharma","headline":"Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPZlFuWV9xQmd1THdqY3ppRmV3U1RhdWpwRWEyYmhwV254NDkxMmIyVXE2Ti1oOFVCdXc5WnVUMGVfZXpRMTRRZ2FPdnYzT21KMkQ1NGR4Zm9QSUdjbDhXOXRzSk9wRVFlcUZDVmdScG4zd2J6XzQ5OGU0Vll5cEl6T2UzdTZ3VW5lSHlOeGdmNk5qR25tdjFUZXlRaXZRQUFr?oc=5","date":"2020-05-17","type":"pipeline","source":"Healthcare Digital","summary":"Cipla plans to invest Rs 500cr to set up API units - Healthcare Digital","headline":"Cipla plans to invest Rs 500cr to set up API units","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBQZW9FenN0T0dLZGtVS3RkdXFGT3IzeHRGLWNUbExkSmRuRlJnR1ctelMwa2JtajljYVJzQ3U3cjlHcUQ2WkpWUFVZRDJkdHhlNnBDSjdnYWlzRlhQclFvaFdpSHI?oc=5","date":"2018-03-06","type":"pipeline","source":"BusinessLine","summary":"Cipla Ltd Share/Stock Price Live Today | The HinduBusinessLine - BusinessLine","headline":"Cipla Ltd Share/Stock Price Live Today | The HinduBusinessLine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1lZDk0REZrUTRnU3dGb2ZtWUt2T0hPQlNFT2p2QUFnajFiUE5oLUVfM3V2MnZ4NzI2S1ZnU0RKWVRWR1VvckhlWmltdHp5Y0ZQZFMtYkNwTHVZLWZVVGlILWloRlFTOHJHWHR1eXd1SUdfcjTSAXhBVV95cUxNS2Z4aXo4R2p2dzNxOFJTNnlVclR0WnRBaVhpUGRKUHlLZXM1UDZ6Wkl6c045LUVBaUh5UVZ2TGROQlBlV0hzUllMMWRIUjFpa21WUkxRR21qQ1MtZDFrWE12OVU0XzBiVjQ2azNRWW0zbTNUczFIVXU?oc=5","date":"2018-02-09","type":"pipeline","source":"Express Pharma","summary":"Stempeutics in agreement with Alkem - Express Pharma","headline":"Stempeutics in agreement with Alkem","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2015-11-17","type":"pipeline","source":"Business Standard","summary":"Dr Sudarshan Ballal appointed as Manipal Health Enterprises chairman - Business Standard","headline":"Dr Sudarshan Ballal appointed as Manipal Health Enterprises chairman","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}